Skip to main content

Table 3 Angiographic data and management of HIV-positive compared to HIV-negative patients

From: The 12-month period prevalence and cardiac manifestations of HIV in patients with acute coronary syndrome at a tertiary hospital in Cape Town, South Africa: a retrospective cross-sectional study

Outcome, n (%) HIV+ (n = 30) HIV- (n = 90) p-value
Culprit coronary artery
 Left main stem 0 (0.0%) 2 (2.2%) 1
 Left anterior descending 16 (53.3%) 38 (42.2%) 0.299
 Diagonal (1st branch) 1 (3.3%) 5 (5.6%) 1.000
 Circumflex 4 (13.3%) 8 (8.9%) 0.492
 Oblique marginal (1st branch) 1 (3.3%) 3 (3.3%) 1.000
 Right coronary artery 6 (20.0%) 25 (27.8%) 0.476
 Other 1 (3.3%) 1 (1.1%) 0.439
Region affected by STEMI
 Antero-septal 13 (56.5%) 26 (54.2%) 1
 Lateral 9 (39.1%) 11 (22.9%) 0.171
 High-lateral 1 (4.4%) 4 (8.3%) 1
 Inferior 9 (39.1%) 22 (45.8%) 0.620
 Posterior 2 (8.7%) 8 (16.7%) 0.482
 Right ventricle 1 (4.4%) 2 (4.2%) 1
 Other 0 (0.0%) 1 (2.1%) 1
Radiological investigations
 Echocardiogram 22 (73.3%) 77 (85.6%) 0.165
 MRI 1 (3.3%) 6 (6.7%) 0.670
Intervention in those with STEMI
 Thrombolysis 17 (73.9%) 30 (62.5%) 0.341
 PCI 16 (69.6%) 38 (79.2%) 0.375
 Conservative 2 (8.7%) 5 (10.4) 0.820
Discharge medication
 Antiplatelet 30 (100.0%) 90 (100.0%) 1
 Angiotensin converting enzyme-inhibitor 26 (86.7%) 79 (87.8%) 1
 Angiotensin receptor blocker 1 (3.3%) 7 (7.8%) 0.678
 Beta-blocker 30 (100.0%) 86 (95.6%) 0.571
 Statin 28 (93.3%) 90 (100.0%) 0.061
  Simvastatin 25 (92.6%) 88 (97.8%) 0.227
  Atorvastatin 2 (7.4%) 2 (2.2%) 0.227
 Nitrate 2 (6.7%) 9 (10.0%) 0.729
 Calcium-channel blocker 0 (0.0%) 6 (6.7%) 0.335
 Thiazide diuretic 0 (0.0%) 7 (7.8%) 0.190
 Loop diuretic 5 (16.7%) 17 (18.9%) 1
 Potassium-sparing diuretic 1 (3.3%) 1 (1.1%) 0.439
  1. STEMI ST-elevation myocardial infarction, MRI magnetic resonance imaging, PCI percutaneous coronary intervention